Scandinavian Real Heart AB Logo

Scandinavian Real Heart AB

Develops a total artificial heart for patients awaiting a heart transplant.

HEART | ST

Overview

Corporate Details

ISIN(s):
SE0006256798 (+3 more)
LEI:
549300HFGZRJQVLZI163
Country:
Sweden
Address:
Kopparbergsvägen 6, 722 13 Västerås

Description

Scandinavian Real Heart AB is a medical technology company developing a total artificial heart (TAH) for patients with life-threatening, end-stage heart failure. Its main product, the Realheart® TAH, is designed to completely replace a diseased heart, primarily serving as a transitional solution for patients awaiting a heart transplant. A key innovation of the device is its ability to mimic the natural heart's function by generating a pulsatile blood flow, which is intended to more closely replicate the body's physiological circulation. The company's objective is to save lives and improve the quality of life for individuals with advanced heart conditions. The device has received a Humanitarian Use Device (HUD) designation from the U.S. Food and Drug Administration (FDA).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Scandinavian Real Heart AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Scandinavian Real Heart AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Scandinavian Real Heart AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-17 Magnus Öhman Other Buy 4,500 51,300.00 SEK
2025-01-17 Magnus Öhman Other Buy 500 5,750.00 SEK
2025-01-16 Magnus Öhman Other Buy 500 5,650.00 SEK
2025-01-16 Magnus Öhman Other Buy 500 5,550.00 SEK
2025-01-16 Magnus Öhman Other Buy 500 5,515.60 SEK
2025-01-16 Magnus Öhman Other Buy 200 2,180.00 SEK
2024-11-19 Azad Najar Other Other 409,000 N/A

Peer Companies

RxSight, Inc. Logo
Develops the only intraocular lens adjustable after cataract surgery.
United States of America
RXST
Safe S.A. Logo
Co-designs and produces cast steel components for various industrial applications.
France
ALSAF
Sanara MedTech Inc. Logo
Develops and markets a portfolio of surgical, wound care, and skin care products.
United States of America
SMTI
SANYU CO.,LTD. Logo
Manufactures and sells steel products like polished bars, wire, and precision machinery.
Japan
5697
Scandinavian ChemoTech AB Logo
Develops electroporation technology for treating tumors in humans and animals.
Sweden
CMOTEC
Schott Pharma Logo
Manufactures drug containment and delivery systems for injectable drugs.
Germany
1SXP
SD BIOSENSOR  INC. Logo
Develops and manufactures point-of-care in-vitro diagnostic solutions and biosensors.
South Korea
137310
SeaStar Medical Holding Corp Logo
Develops therapies for critically ill patients with organ failure from hyperinflammation.
United States of America
ICU
SEJONG MEDICAL Co.Ltd., Logo
Develops and manufactures single-use instruments for laparoscopic surgery.
South Korea
258830
Senseonics Holdings, Inc. Logo
Develops and commercializes long-term, implantable glucose monitoring systems.
United States of America
SENS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.